An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
For the treatment of giardiasis and cutaneous leishmaniasis and the management of malignant effusions.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.